EQO is a pioneering biotechnology company, but our focus does not sit within the realm of human health. Our commitment is to harness the power of biotechnology to confront challenges in aquatic ecosystems - our lakes, rivers, wetlands, estuaries, and other vital water assets.

​

At EQO, we've innovated two next-generation field tools: the Osprey and the Calypso. Using our unique proprietary technology, these tools capture the eRNA of specific animal or microbial populations. But we don't stop there; our comprehensive lab support goes a step further. We offer eRNA and eDNA sample processing, as well as metagenomic and bioinformatic tools to assist our clients in three key areas: 1) thwarting invasive species infestations, 2) monitoring native and endangered species, and 3) identifying toxic organisms.

​

Our clientele, spanning both public and private sectors, are those who own or manage vital water assets. These include lakes, rivers, reservoirs, wetlands, or other watershed 'assets' that are under increased stress due to the impacts of climate change and pollution runoff. And much like a person combating illness, the journey to restoring the health, safety, and biodiversity of these aquatic ecosystems begins with accurate diagnostics.

​